Oncology

George Clinical is uniquely placed to meet the increasingly complex and specialized demands of modern oncology research, and as such demonstrating product value in terms of clinical effectiveness, specialized cohorts and tolerability.

Oncology

George Clinical is a leading provider of oncology trial, scientific, and operational solutions throughout the Asia-Pacific, USA and Europe.

As a leader in the design and delivery of care-based, oncology research, George Clinical has access to significant global investigator networks, experienced project teams, oncology experts, and scientific leaders to design and deliver oncology trials, with the latest immunotherapies, to the highest scientific standards. By accessing some of the world’s most experienced medical, scientific and operational teams in oncology research, George Clinical is uniquely placed to meet the increasingly complex and specialized demands of modern oncology research, and thus demonstrates product value in terms of clinical effectiveness, specialized cohorts and tolerability.

Exceptional medical, scientific and operational expertise makes George Clinical an ideal partner for clinical trials throughout North America, Europe and the Asia-Pacific.

Oncology Expertise

George Clinical has extensive experience in all phases of oncology programs including, MTD, early Phase I, II and III and late-phase trials, health economics and outcomes research. Our full services team is comprised of scientific leaders, doctors, nurses, biostatisticians and trial management professionals that work together to ensure timely delivery of quality trial data on time and on budget.

George Clinical offers a unique combination of scientific leadership and operational capabilities to design and deliver studies for sponsors, no matter the complexity. George Clinical offers:

  • Full service clinical operations and capabilities with experience in the conduct of over 300 oncology studies
  • A robust network of practicing medical oncologists with expertise across a range of tumor types, hematologic diseases and the latest immunotherapies, who actively participate in the design and delivery of our studies
  • World-class Health Economics and Statistics scientific leaders with expertise in large, multi-regional datasets

George Clinical’s extensive experience in oncology trials provides sponsors with the confidence that their oncology trial will be delivered on time, on budget and to the highest scientific standards.

Our clinical trial services in oncology clinical trials include:

George Clinical's Oncology Scientific Leadership

Lee Schwartzberg, MD, FACP, is a medical oncologist and hematologist, senior partner and medical director at the community-based private practice West Cancer Center. Dr. Schwartzberg is founding Editor-in-Chief for Oncologystat.com and was the founding Editor-in-Chief for Community Oncology Journal. He serves as the Division Chief of Hematology/Oncology and Professor of Medicine at the University of Tennessee Health Science Center. Dr. Schwartzberg also serves on the Board of Directors for the National Comprehensive Cancer Network. His research interests include breast cancer, supportive care and developmental therapeutics, having published over 110 peer-reviewed publications.

Dr. Ari VanderWalde is an internationally-recognized cancer researcher, Dr. VanderWalde holds a dual appointment with the University of Tennessee Health Science Center as Associate Vice Chancellor of Research and Assistant Professor, Hematology/Oncology.

Dr. VanderWalde previously served as United States Medical Lead and Clinical Research Medical Director with Amgen Inc., directing US global development of talimogene laherparepvec, a novel viral-based immunotherapeutic that has shown efficacy in late-stage clinical trials in melanoma. As an expert in melanoma, Dr. VanderWalde has collaborated with some of the nation’s thought leaders and participated on advisory boards with top experts in the field.

A native of Memphis, TN, Dr. Chandler attended Christian Brothers University where he received a degree in electrical engineering. He went on to pursue a career in medicine and attended the University Of Tennessee School Of Medicine, receiving his Medical Degree in 2003. Dr. Chandler also completed his postdoctoral training in Internal Medicine and Pediatrics at the University Of Tennessee School Of Medicine. During his medical rotations he had the opportunity to meet and work with Drs. Lee Schwartzberg and Arnel Pallera.  Dr. Chandler went on to receive a fellowship in Medical Oncology/Hematology at The Ohio State University Medical Center in Columbus where he concentrated on leukemia research and immunology. With a strong research interest, Dr. Chandler has co-authored several articles appearing in peer-reviewed publications and presented nationally.

Dr. Ralph V. Boccia is Medical Director of the Center for Cancer and Blood Disorders in Bethesda, Maryland, and Clinical Associate Professor of Medicine at Georgetown University in Washington, DC. He also serves as the Chief Medical Officer for the International Oncology Network (ION). Dr. Boccia completed a residency in internal medicine at the University of California, Los Angeles (UCLA). He then did a fellowship in hematology/oncology, and bone marrow transplant at UCLA and the West Los Angeles VA Medical Center, and was then recruited to the Medicine Branch at the National Institutes of Health’s National Cancer Center in Bethesda.

Dr. Boccia is a Fellow of the American College of Physicians (ACP) and a member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and Multinational Association for Supportive Care in Cancer (MASCC). He is on the editorial board for the Journal of Hematology & Oncology and Oncology and Biotech News. Dr. Boccia has authored or co-authored numerous articles in more than 50 publications. He has been voted among Top Doctors in America, and Best Doctors in Washington, DC since 2002.

Join Our Mailing List

required
required
required
required

Add George Clinical to your network